What is the purpose of SpreadtheCure.org®?
We are a nationwide 501(c)(3) organization registered under EIN 83-1140831. Our goal is to raise awareness about the cure for Hemophilia and other genetic diseases. By raising awareness about real cures for people with genetic diseases, we can reduce healthcare costs for everyone. For example, it is estimated that $1M will cure one child with Hemophilia Type A for life. The cost of current medications, and subsequent surgeries, to treat this same child for life would be in the tens of millions. Real cures save real people from real suffering and it takes an enormous financial strain off of our overburdened healthcare system.

They Thought Hemophilia Was a "Lifelong Thing." They May Be Wrong. | NY Times/NYTimes.com

How are we different than other non-profits?
We are focused on raising awareness about real cures. We hope to bring healthcare and treatment costs down by raising awareness about ethical & safe revelations in CRISPR and modern innovations in curative medicine.

A simple guide to CRISPR, one of the biggest science stories of the decade | VOX.com

The current treatment costs for many genetic diseases puts a tremendous financial, emotional, and physical strain on the people and families affected, not to mention the healthcare system as a whole. Our vision is to raise awareness about real cures and hopefully bring costs down. This is a complicated issue with various safety & ethical implications, so please forgive any errors or omissions we may make as we try to remove obstacles and ‘Spread the Word’ about curative medicine as an option.
+ Ryan/STC Founder

‘Spread the Cure’ in the News

Spread the Cure raises awareness and capital to cure those with hemophilia | Palm Coast Observer/PalmCoastObserver.com

What is Hemophilia?
Hemophilia is a deadly bleeding disorder that prevents the blood from clotting normally if not treated. The primary symptom is uncontrolled internal bleeding in different areas of the body. The amount of bleeding depends on the severity of the disease. Internal bleeding, which commonly occurs in the spaces around joints, results in debilitating pain and swelling. The cumulative effects of internal bleeding can lead to permanent damage of joints, muscles, organs, and even premature death.
National Hemophilia Foundation & those directly affected by Hemophilia

How many people are affected by Hemophilia?
Hemophilia A occurs in 1 in 5,000 live male births. Hemophilia A is about four times as common as Hemophilia B About 20,000 people in the United States have Hemophilia A. The worldwide incidence of hemophilia is not well known, but is estimated at more than 400,000 people. Approximately 75 percent of people with hemophilia around the world still receive inadequate treatment or have no access to treatment. 
– National Hemophilia Foundation 

Is Hemophilia lifelong?
People born with hemophilia have it for life.
World Federation of Hemophilia

The disease is typically inherited in an X-linked recessive pattern.
– U.S. National Library of Medicine

What are the costs associated with Hemophilia?
On average, it costs at least $270,000 every year to treat one person with current medications. The cost of treating related issues (such as joint replacements, surgeries or both) can cost millions over a lifetime. The cost of lost productivity, the financial strain on families, the ripple effect across the healthcare system, the psychological and emotional distress, and the inability to lead a "normal" life due to a single gene being out of place are beyond computation.

This is one of many multi-billion-dollar diseases for various industries, and it is time to shed light on the excessive medical expenses associated with them. Please help us provide those suffering from it with a realistic path of access to the cure. Preliminary reports suggest the cost for the 'one-injection somatic cure' will be very expensive ... well beyond the means of most.

First US drug priced at more than $1 million may be on the horizon | CNBC/cnbc.com

Is there a cure?
Yes, thanks to revelations in CRISPR & modern innovations in medicine. The ‘one-injection somatic cure’ exists and is currently in clinical trials in the USA. It provides relief to the individual, but it currently does not prevent the recessive gene (or spontaneous gene mutations) from being passed to future generations. It is estimated that 1 in 3 people born with hemophilia get it through a spontaneous gene mutation.

SpreadtheCure.org is working diligently to raise awareness and provide a path to safe, affordable & timely access to a cure for those affected by this disease.

Gene Therapy Yields Dramatic Results in Hemophilia. | Forbes/Forbes.com